Gary K. Lee Lyell Immunopharma, Inc. (LYEL) insider trading activity
Gary K. Lee is Chief Scientific Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 8,957 shares of LYEL, which is worth approximately $94,675. The most recent transaction as insider was on Aug 12, 2025, when has been sold 136 shares (Common Stock) at a price of $10.34 per share, resulting in proceeds of $1,406. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
8.96K
94.93%
3M change
83.0%
12M change
Total Value Held
$94,675
Gary K. Lee Transaction History
GKL
Gary K. Lee
Chief Scientific Officer
South San Francisco, CA